ReviewCancer metastasis reviews2021

Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners.

Marek Z Wojtukiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.